RFK Jr. CDC Panel: Vaccine Skeptics Appointed

Robert F. Kennedy Jr.’s ongoing overhaul of the Centers for Disease Control and Prevention’s (CDC) vaccine advisory committee is escalating a deliberate strategy to reshape public health messaging around immunization – and it’s a move that’s drawing sharp criticism from established medical communities. The appointment of Dr. Adam Urato and Dr. Kimberly Biss to the Advisory Committee on Immunization Practices (ACIP) isn’t simply about filling vacancies; it’s a clear signal of a fundamental shift in the administration’s approach to vaccine policy, one increasingly aligned with skepticism and, in some cases, outright opposition to prevailing scientific consensus.

This isn’t an isolated incident. Kennedy’s decision in June to dismiss the previous ACIP panel and replace it with his own selections was widely condemned as politically motivated. The appointments of Urato and Biss build on that foundation, solidifying a pattern of prioritizing individuals who have actively questioned established vaccine protocols. Biss, in particular, has become a prominent voice in anti-vaccine circles, publicly attributing menstrual irregularities, surgeries, and even hysterectomies to Covid-19 vaccination – claims that have been refuted by numerous medical experts. Her evolution from not being “anti-vaxxer” to actively identifying as one, coupled with her expressed admiration for Kennedy himself, underscores the ideological alignment driving these appointments.

Urato’s concerns center on both vaccine safety during pregnancy and the potential risks associated with SSRI antidepressants. His petition to the FDA for warning labels on SSRIs, while raising legitimate questions about medication side effects, is part of a broader pattern of challenging established medical guidelines. His comparison of vaccine manufacturers to cigarette companies – accusing them of downplaying risks – is a particularly inflammatory statement that further fuels distrust in public health institutions.

The timing of these appointments is also significant. Public trust in institutions, including the CDC, has been eroded in recent years, fueled by misinformation and political polarization. This creates a fertile ground for alternative narratives to take hold, and Kennedy’s actions appear designed to capitalize on that vulnerability. The administration’s focus on “transparency” and “watchdog” functions, as Kennedy stated in his announcement, rings hollow to critics who see it as a pretext for undermining scientific consensus.

The Forward Look

The immediate consequence of these appointments will likely be increased scrutiny and debate surrounding ACIP’s future recommendations. Expect fierce pushback from the medical community and advocacy groups like Protect Our Care, who are already voicing concerns about the politicization of vaccine policy. More importantly, watch for potential challenges to the CDC’s authority and credibility. If ACIP begins to issue recommendations that deviate significantly from established scientific guidelines, it could trigger legal challenges and further erode public trust. The long-term impact could be a decline in vaccination rates, leading to outbreaks of preventable diseases. Furthermore, this situation sets a dangerous precedent for future administrations, potentially opening the door to further politicization of scientific advisory bodies. The next six to twelve months will be critical in determining whether these appointments represent a temporary disruption or a fundamental shift in the landscape of U.S. public health policy.